Analyst Ratings February 9, 2026

Scotiabank Raises Plains All American Price Target to $23 After Mixed Quarter

Analyst maintains Sector Outperform as company issues 2026 EBITDA guidance and reports cost synergies; Q4 2025 results missed expectations

By Priya Menon PAA
Scotiabank Raises Plains All American Price Target to $23 After Mixed Quarter
PAA

Scotiabank raised its price target on Plains All American to $23.00 from $22.00 while keeping a Sector Outperform rating, noting a mixed quarterly report but an overall constructive view. The company provided 2026 EBITDA guidance of $2.75 billion at the midpoint, reported $150 million in expected synergies and efficiency gains over two years, and lowered its target coverage ratio to 150% while indicating scope for multi-year distribution growth of $0.15 per unit. Plains All American's fourth-quarter 2025 earnings and revenue fell short of expectations, registering EPS of $0.40 versus $0.47 projected and revenue of $10.57 billion versus $13.42 billion expected.

Key Points

  • Scotiabank raised its price target on Plains All American to $23.00 from $22.00 and kept a Sector Outperform rating.
  • Plains All American guided 2026 EBITDA to $2.75 billion at the midpoint, compared with $2.33 billion in the last twelve months.
  • Company expects $150 million in synergies and efficiency gains over two years and signaled room for multi-year distribution growth of $0.15 per unit; sustaining a 150% coverage ratio beyond 2026 would require materially higher 2027 EBITDA than current consensus.

Scotiabank has nudged up its price target for Plains All American to $23.00 from $22.00 and retained a Sector Outperform rating on the stock. The upgraded target sits near a fair value assessment and comes as the company trades close to its 52-week high of $20.77.

Scotiabank characterized the latest quarterly report as "mixed," but maintained a positive stance on the midstream energy firm’s outlook. Central to the analyst update was Plains All American’s 2026 EBITDA guidance, which the company set at $2.75 billion at the midpoint - a level that effectively meets current consensus expectations. By comparison, the company’s last-twelve-months EBITDA stands at $2.33 billion, indicating a modest step-up implied by the 2026 guidance.

The company outlined expected synergies and cost reductions totaling $150 million across a two-year window. That package was described as comprising $50 million in cost synergies complemented by $100 million in efficiency gains. Scotiabank noted these measures were generally in line with investor expectations and flagged their potential to help mitigate the company's relatively low gross profit margins, which are reported at 6.04%.

On the distribution front, Plains All American lowered its target coverage ratio to 150% and disclosed room for multi-year distribution growth of $0.15 per unit. Scotiabank emphasized that sustaining a 150% coverage ratio beyond 2026 would hinge on 2027 EBITDA being materially above the current consensus figure of $2.7 billion. The bank’s analysis indicates the implied EBITDA growth necessary to maintain that coverage ratio for an additional year points toward stronger operational performance than is presently baked into market consensus.

Investors were also focused on the company's fourth-quarter 2025 reported results. Plains All American posted earnings per share of $0.40, missing the analyst projection of $0.47. Revenue for the quarter came in at $10.57 billion, well below the expected $13.42 billion. Those shortfalls were highlighted as a material element of the quarter and a factor for market participants evaluating the company’s near-term trajectory.

While Scotiabank’s price-target increase and maintained Sector Outperform rating suggest a favorable medium-term view, the company’s missed earnings and revenue targets underscore ongoing execution and market-demand questions. Investors and analysts will likely track whether the outlined synergies and efficiency gains materialize as planned and whether 2027 EBITDA moves meaningfully above current consensus, which would be necessary to preserve the revised coverage posture without compressing distributions.

Key items for observers to monitor include the realization of the $150 million in synergies and efficiencies, progress toward the $2.75 billion 2026 EBITDA guidance, and any updates to distribution policy tied to coverage ratio targets. Each of these factors bears directly on cash flow and distribution sustainability for holders of the company’s units and on valuations used by rating analysts.

Risks

  • Quarterly results missed analyst expectations - Q4 2025 EPS of $0.40 versus $0.47 expected and revenue of $10.57 billion versus $13.42 billion expected - which could pressure near-term sentiment and valuations.
  • Maintaining the lowered 150% coverage ratio beyond 2026 depends on 2027 EBITDA materially exceeding the current consensus of $2.7 billion, introducing execution and forecasting risk.
  • Realization risk for the stated $150 million in synergies and efficiency gains over two years, which are needed to help improve weak gross profit margins of 6.04%.

More from Analyst Ratings

Stifel Lowers JFrog Target Citing AI-Driven Security Concerns; Maintains Buy Rating Feb 22, 2026 HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026